Mostrar o rexistro simple do ítem

dc.contributor.authorDalmao-Fernández, Andrea
dc.contributor.authorHermida Gómez, Tamara
dc.contributor.authorLund, Jenny
dc.contributor.authorVázquez-Mosquera, María E.
dc.contributor.authorRego-Pérez, Ignacio
dc.contributor.authorGaresse, Rafael
dc.contributor.authorBlanco García, Francisco J
dc.contributor.authorFernández-Moreno, Mercedes
dc.date.accessioned2021-09-22T08:53:18Z
dc.date.issued2022-05
dc.identifier.citationDalmao-Fernández A, Hermida-Gómez T, Lund J, Vazquez-Mosquera ME, Rego-Pérez I, Garesse R, Blanco FJ, Fernández-Moreno M. Mitochondrial DNA from osteoarthritic patients drives functional impairment of mitochondrial activity: a study on transmitochondrial cybrids. Cytotherapy. 2021 May;23(5):399-410.es_ES
dc.identifier.issn1465-3249
dc.identifier.urihttp://hdl.handle.net/2183/28504
dc.description.abstract[Abstract] With the redefinition of osteoarthritis (OA) and the understanding that the joint behaves as an organ, OA is now considered a systemic illness with a low grade of chronic inflammation. Mitochondrial dysfunction is well documented in OA and has the capacity to alter chondrocyte and synoviocyte function. Transmitochondrial cybrids are suggested as a useful cellular model to study mitochondrial biology in vitro, as they carry different mitochondrial variants with the same nuclear background. The aim of this work was to study mitochondrial and metabolic function of cybrids with mitochondrial DNA from healthy (N) and OA donors. In this work, the authors demonstrate that cybrids from OA patients behave differently from cybrids from N donors in several mitochondrial parameters. Furthermore, OA cybrids behave similarly to OA chondrocytes. These results enhance our understanding of the role of mitochondria in the degeneration process of OA and present cybrids as a useful model to study OA pathogenesis.es_ES
dc.description.sponsorshipThis study was supported by grants from Fondo de Investigación Sanitaria, Centro de investigación biomédica en Red, Bioingeniería, Biomateriales y Nanomedicina CB06/01/0040, Spain; RETIC-RIER-RD16/0012/0002; PI12/00329; PI14/01254; PI16/02124; PIE16/00054; PRB3-ISCIII-PT17/0019; and PI17/00210, integrated into the National Plan for Scientific Program, Development and Technological Innovation 2013–2016, and funded by the El Instituto de Salud Carlos III, General Subdirection of Assessment and Promotion of Research–European Regional Development Fund “A way of making Europe.” MF-M is supported by Contrato Centro de investigación biomédica en Red, Bioingeniería, Biomateriales y Nanomedicina. AD-F is supported by FIS PI17/00210 and was the beneficiary of short-term scientific missions from MitoEAGLE (COST Action CA15203) for a research stat at the University of Oslo. JL is supported by the Universty of Oslo. MEV-M is supported by FIS PI16/02124. IR-P is supported by Contrato Miguel Servet tipo II-Fondo de Investigación Sanitaria (CPII17/00026).es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0012%2F0002/ES/Red de Investigación en Inflamación y Enfermedades Reumáticas (RIER)es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Acción Estratégica de Salud/PI12%2F00329/ES/PROYECTO PROTEOMA HUMANO ESPAÑOL: Aplicacion en Enfermedades Reumatologicases_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/PI14%2F01254/ES/Diseño de un modelo celular de cíbridos transmitocondriales para la búsqueda de biomarcadores epigenéticos para el diagnóstico de distintos fenotipos de artrosises_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/PI16%2F02124/ES/Determinación de índices predictivos de diagnóstico y pronóstico de artrosis de rodilla mediante la validación de biomarcadores proteicoses_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/PIE16%2F00054/ES/Identification of clinical phenotypes on Osteoarthritis (OA) disease through Big Data approaches_ES
dc.description.sponsorshipInstituto de Salud Carlos III; PRB3-ISCIII-PT17%2F0019es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/ISCIII/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/PI17%2F00210/ES/IDENTIFICACION DE MARCADORES GENETICOS MITOCONDRIALES DE PROGRESION RAPIDA DE ARTROSIS DE RODILLA MEDIANTE TECNICAS DE SECUENCIACION MASIVA.es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/ISCIII/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/PI17%2F00210/ES/IDENTIFICACION DE MARCADORES GENETICOS MITOCONDRIALES DE PROGRESION RAPIDA DE ARTROSIS DE RODILLA MEDIANTE TECNICAS DE SECUENCIACION MASIVA.es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; CPII17/00026
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relation.urihttps://doi.org/10.1016/j.jcyt.2020.08.010es_ES
dc.titleMitochondrial DNA from osteoarthritic patients drives functional impairment of mitochondrial activity: a study on transmitochondrial cybridses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessinfo:eu-repo/semantics/embargoedAccesses_ES
dc.date.embargoEndDate2022-05-01es_ES
dc.date.embargoLift2022-05-01
UDC.journalTitleCytotherapyes_ES
UDC.volume23es_ES
UDC.issue5es_ES
UDC.startPage399es_ES
UDC.endPage410es_ES


Ficheiros no ítem

Thumbnail
Thumbnail

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem